| 12005236 |
Devices and methods for delivering a lyophilized medicament |
Eric S. Edwards, Evan T. Edwards, Paul F. Meyers |
2024-06-11 |
| 10695495 |
Devices and methods for delivering a lyophilized medicament |
Eric S. Edwards, Evan T. Edwards, Paul F. Meyers |
2020-06-30 |
| 10322239 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2019-06-18 |
| 10226583 |
Devices and methods for delivering medicaments from a multi-chamber container |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2019-03-12 |
| 10220158 |
Devices and methods for delivering opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Glen L. Kelley, Paul F. Meyers |
2019-03-05 |
| 10183116 |
Devices and methods for delivering medicaments from a multi-chamber container |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2019-01-22 |
| 10143792 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata |
2018-12-04 |
| 9814838 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2017-11-14 |
| 9522235 |
Devices and methods for delivering medicaments from a multi-chamber container |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2016-12-20 |
| 9517307 |
Devices and methods for delivering opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Glen L. Kelley, Paul F. Meyers |
2016-12-13 |
| 9474869 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata |
2016-10-25 |
| 9173999 |
Devices and methods for delivering medicaments from a multi-chamber container |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2015-11-03 |
| 9022022 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata |
2015-05-05 |
| 8939943 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers |
2015-01-27 |
| 8627816 |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
Eric S. Edwards, Evan T. Edwards, Mark J. Licata |
2014-01-14 |
| 7501113 |
Aerosol formulations and aerosol delivery of buprenorphine |
Justin Poklis, Matthew Baker |
2009-03-10 |
| 7410635 |
Aerosol formulations and aerosol delivery of scopolamine |
Justin Poklis, Matthew Baker |
2008-08-12 |
| 6451285 |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
Michael Brucato, Maria Buenafe |
2002-09-17 |
| 6290930 |
Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
Michael Brucato, Maria Buenafe, Kelly A. Cavanaugh, Raul A. Medina |
2001-09-18 |
| 6004537 |
Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
Michael Brucato, Maria Buenafe, Kelly A. Cavanaugh |
1999-12-21 |
| 5508023 |
Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
Peter R. Byron |
1996-04-16 |
| 5492688 |
Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
Peter R. Byron |
1996-02-20 |